Document Detail

A method of determining the specific volume of liposomes with Turnbull blue
MedLine Citation:
PMID:  9493253     Owner:  NLM     Status:  MEDLINE    
A method for measuring the specific volume of liposomes by using ferricyanide as a maker is proposed. Ferricyanide is determined by the formation of Turnbull's blue. Advantages of the use of this reaction are an eightfold increase in the sensitivity and the possibility to determine the marker compound in the spectral region (730 nm) free of any considerable interference of natural compounds. Results of the use of this method for measuring the specific volume of liposomes prepared by ultrasonic treatment of a lipid suspension are reported.
L S Lagutina; V A Shteĭn-Margolina; D I Bondarenko; K F Shol'tz
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Prikladnaia biokhimiia i mikrobiologiia     Volume:  33     ISSN:  0555-1099     ISO Abbreviation:  Prikl. Biokhim. Mikrobiol.     Publication Date:    1997 Nov-Dec
Date Detail:
Created Date:  1998-04-03     Completed Date:  1998-04-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0023416     Medline TA:  Prikl Biokhim Mikrobiol     Country:  RUSSIA    
Other Details:
Languages:  rus     Pagination:  655-9     Citation Subset:  IM    
Bach Institute of Biochemistry, Russian Academy of Sciences, Moscow, Russia.
Vernacular Title:
Metod opredeleniia udel'nogo ob''ema liposom s pomoshch'iu Turnbulevoĭsini.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Coloring Agents*
Microscopy, Electron
Sensitivity and Specificity
Reg. No./Substance:
0/Coloring Agents; 0/Ferricyanides; 0/Ferrocyanides; 0/Liposomes; 13408-62-3/hexacyanoferrate III; 25869-98-1/potassium iron(III) hexacyanoferrate (II)

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Preparation and characteristics of antibodies to a sulfur-containing hapten, mimicking the transitio...
Next Document:  Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regi...